Using the Emergency Department Clinical Decision Unit for Acute Decompensated Heart Failure
Tóm tắt
Từ khóa
Tài liệu tham khảo
Packer, 1999, Consensus recommendations for the management of chronic heart failure, Am J Cardiol, 83, 1A, 10.1016/S0002-9149(99)00358-6
Massie, 1997, Evolving trends in epidemiologic factors of heart failure: rationale for preventative strategies and comprehensive disease management, Am Heart J, 133, 703, 10.1016/S0002-8703(97)70173-X
CMS 2001 in-patient discharge data base: MEDPAR, DRG 427.
Peacock, 2002, Effective observation unit treatment of decompensated heart failure, Congest Heart Fail, 8, 68, 10.1111/j.1527-5299.2002.01519.x
USDHHS: Heart failure: evaluation and care of patients with left-ventricular systolic dysfunction (Clinical Practice Guideline, Number 11, AHCPR publication No. 94–0612). US Department of Health and Human Services, Washington, DC, June, 1994.
Marantz, 1988, The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria, Circulation, 77, 607, 10.1161/01.CIR.77.3.607
Hobbs, 1994, Congestive heart failure. Current and future strategies to decrease mortality, Postgrad Med, 96, 167, 10.1080/00325481.1994.11945915
Clemens, 1998, Pharmacokinetics and biological actions of subcutaneously administered human brain natriuretic peptide, J Pharmacol Exp Ther, 87, 67
Nakao, 1991, Biosynthesis, secretion, and receptor selectivity of human brain natriuretic peptide, Can J Physiol Pharmacol, 59, 1500, 10.1139/y91-225
Cowie, 1997, Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care, Lancet, 350, 1349, 10.1016/S0140-6736(97)06031-5
Mair, 1999, Natriuretic peptides in assessment of left-ventricular dysfunction, Scan J Clin Invest, 9, 132, 10.3109/00365519909168337
Struthers, 1994, Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use?, BMJ, 308, 1615, 10.1136/bmj.308.6944.1615
Peacock, 2001, The incidence of elevated cardiac enzymes in decompensated heart failure, Acad Emerg Med, 5, 552
Peacock, 2004, Heart failure with an elevated troponin is associated with increased morbidity and mortality: an ADHERE registry analysis, Ann Emerg Med, 44, S72, 10.1016/j.annemergmed.2004.07.238
Remes, 1991, Validity of clinical diagnosis of heart failure in primary health care, Eur Heart J, 12, 315, 10.1093/oxfordjournals.eurheartj.a059896
Stevenson, 1998, The limited availability of physical signs for estimating hemodynamics in chronic heart failure, JAMA, 261, 884, 10.1001/jama.1989.03420060100040
Davis, 1996, Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction, Br Med J, 312, 222, 10.1136/bmj.312.7025.222
Marantz, 1990, Clinical diagnosis of congestive heart failure in patients with acute dyspnea, Chest, 97, 776, 10.1378/chest.97.4.776
Chakko, 1991, Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care, Am J Med, 90, 353, 10.1016/0002-9343(91)80016-F
Kono, 1992, Clinical significance of normal cardiac silhouette in dilated cardiomyopathy; evaluation based upon echocardiography and magnetic resonance imaging, Jpn Circ J, 56, 359, 10.1253/jcj.56.359
Ruskin, 1987, Detection of pleural effusions on supine chest radiographs, AJR Am J Roentgenol, 148, 681, 10.2214/ajr.148.4.681
Chait, 1972, The bedside chest radiograph in the evaluation of incipient heart failure, Radiology, 105, 563, 10.1148/105.3.563
Butman, 1993, Bedside cardiovascular examination in patients with severe chronic heart failure: importance of resting or inducible jugular venous distention, J Am Coll Cardiol, 22, 968, 10.1016/0735-1097(93)90405-P
Marantz, 1993, Clinical diagnosis of congestive heart failure in patients with acute dyspnea, Circulation, 88, 107
Peacock, 2000, Bioimpedance monitoring for detecting pulmonary fluid in heart failure: equal to chest radiography?, Congest Heart Fail, 6, 86, 10.1111/j.1527-5299.2000.80141.x
Dao, 2001, Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting, J Am Coll Cardiol, 37, 379, 10.1016/S0735-1097(00)01156-6
McKee, 1971, The natural history of congestive heart failure: The Framingham Study, N Engl J Med, 285, 1441, 10.1056/NEJM197112232852601
Francis, 1995, Open access echocardiography in management of heart failure in the community, BMJ, 310, 634, 10.1136/bmj.310.6980.634
ACC/AHA. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult. [Cited March 18, 2002]. Available from: http://www.acc.org/clinical/guidelines/failure/I_introduction.
Wheeldon, 1993, Echocardiography in chronic heart failure in the community, Q J Med, 86, 255
Maeda, 1998, Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction, Am Heart J, 135, 825, 10.1016/S0002-8703(98)70041-9
Yamamoto, 1996, Superiority of brain natriuretic peptide as a humoral marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy, Hypertension, 28, 988, 10.1161/01.HYP.28.6.988
Omland, 1996, Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide, Circulation, 93, 1963, 10.1161/01.CIR.93.11.1963
Kazanegra, 2001, A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study, J Card Fail, 7, 21, 10.1054/jcaf.2001.23355
Jensen, 1997, A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases, Scand J Clin Lab Invest, 57, 529, 10.3109/00365519709084604
Buckley, 1993, Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension, J Hum Hypertens, 3, 345
Wallen, 1997, Brain natriuretic peptide in an elderly population, J Intern Med, 242, 307, 10.1046/j.1365-2796.1997.00184.x
Sayama, 2000, Relationship between left ventricular geometry and brain natriuretic peptide levels in elderly subjects, Gerontology, 46, 71, 10.1159/000022137
Lernfelt, 1991, Aging and left ventricular function in elderly healthy people, Am J Cardiol, 68, 547, 10.1016/0002-9149(91)90797-O
Kohse, 1993, Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients, Clin Nephrol, 40, 83
McCullough, 2003, B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study, Am J Kidney Dis, 41, 571, 10.1053/ajkd.2003.50118
Cheng, 2001, A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study, J Am Coll Cardiol, 37, 386, 10.1016/S0735-1097(00)01157-8
Tang, 2003, Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure, Circulation, 108, 2964, 10.1161/01.CIR.0000106903.98196.B6
Niinuma, 1998, Plasma B-type natriuretic peptide measurement in a multiphasic health screening program, Cardiology, 90, 89, 10.1159/000006825
Davis, 1994, Plasma brain natriuretic peptide in assessment of acute dyspnoea, Lancet, 343, 440, 10.1016/S0140-6736(94)92690-5
McDonagh, 1998, Biochemical detection of left-ventricular systolic dysfunction, Lancet, 351, 9, 10.1016/S0140-6736(97)03034-1
Maisel, 2002, Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure, N Engl J Med, 347, 161, 10.1056/NEJMoa020233
Bettencourt, 2000, Evaluation of brain natriuretic peptide in the diagnosis of heart failure, Cardiology, 93, 19, 10.1159/000006997
Fujimora, 2000, Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy, J Card Fail, 6, 3, 10.1016/S1071-9164(00)80004-4
Nishikimi, 1996, Antihypertensive therapy reduces increased plasma levels of adrenomedullin and brain natriuretic peptide concomitant with regression of left ventricular hypertrophy in a patient with malignant hypertension, Hypertens Res, 19, 97, 10.1291/hypres.19.97
Selvais, 1998, Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation, Eur J Clin Invest, 28, 636, 10.1046/j.1365-2362.1998.00338.x
Tsutamoto, 1999, Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction, Eur Heart J, 20, 1799, 10.1053/euhj.1999.1746
Yu, 1999, Plasma brain natriuretic peptide—an independent predictor of cardiovascular mortality in acute heart failure, Eur J Heart Fail, 1, 59, 10.1016/S1388-9842(98)00010-5
Hammerer-Lercher, 2001, Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction, Clin Chim Acta, 310, 193, 10.1016/S0009-8981(01)00578-2
Harrison, 2002, B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea, Ann Emerg Med, 39, 131, 10.1067/mem.2002.121483
Arroliga, 2001, Noninvasive positive pressure ventilation in acute respiratory failure: does it improve outcomes?, Cleve Clin J Med, 68, 677, 10.3949/ccjm.68.8.677
Peacock, 2003, Early initiation of intravenous therapy improves heart failure outcomes: an analysis from the ADHERE registry database, Ann Emerg Med, 42, S26, 10.1016/j.annemergmed.2019.08.072
Peacock, 2001, Observation unit management of heart failure, Emerg Med Clin North Am, 19, 209, 10.1016/S0733-8627(05)70176-0
Peacock, 1998, Inpatient versus emergency department observation unit management of heart failure, Ann Emerg Med, 32, S46
Fonarow, 2005, Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis, JAMA, 293, 572, 10.1001/jama.293.5.572
Diercks, 2004, Identification of emergency department patients with decompensated heart failure at low risk for adverse events and prolonged hospitalization, J Cardiac Failure, 10, S114, 10.1016/j.cardfail.2004.06.375
Burkhardt, 2004, Elevation in blood urea nitrogen predicts a lower discharge rate from the observation unit, Ann Emerg Med, 44, S99, 10.1016/j.annemergmed.2004.07.323
Rich, 1995, A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure, N Engl J Med, 333, 1190, 10.1056/NEJM199511023331806
Rich, 1993, Prevention of readmission in elderly patients with congestive heart failure, J Gen Intern Med, 8, 585, 10.1007/BF02599709
Albert, 1999, Patient outcome and costs after implementation of an acute heart failure management program in an emergency department observation unit, J Int Soc Heart Lung Transplant, 18, 92, 10.1016/S1053-2498(99)80247-2
Vinson, 1990, Early readmission of elderly patients with congestive heart failure, J Am Geriatr Soc, 38, 1290, 10.1111/j.1532-5415.1990.tb03450.x
Quaglietti, 2000, Management of the patient with congestive heart failure using outpatient, home, and palliative care, Prog Cardiovasc Dis, 43, 259, 10.1053/pcad.2000.19803
Peacock, 1997, Predictors of unsuccessful treatment for congestive heart failure in the emergency department observation unit, Acad Emerg Med, 4, 494
Cohn, 1991, A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure, N Engl J Med, 325, 303, 10.1056/NEJM199108013250502
Cohn, 1986, Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of the Veterans Administration Cooperative Study, N Engl J Med, 314, 1547, 10.1056/NEJM198606123142404
The SOLVD Investigators, 1991, Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure, N Engl J Med, 325, 293, 10.1056/NEJM199108013250501
The CONSENSUS Trial Study Group, 1987, Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS), N Engl J Med, 315, 1429, 10.1056/NEJM198706043162301
Marcus, 1996, Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial, Circulation, 94, 3184, 10.1161/01.CIR.94.12.3184
Abraham, 1998, Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure, J Card Fail, 4, 37, 10.1016/S1071-9164(98)90506-1
Burger, 1999, Nesiritide is not associated with the proarrhythmic effects of dobutamine in the treatment of decompensated CHF: The PRECEDENT Study, J Card Fail, 5, 178
Elkayam, 2000, The effect of short-term therapy with nesiritide (B-type natriuretic peptide) or dobutamine on long-term survival, J Card Fail, 6, 169
Young, 2000, Rationale and design of the VMAC Trial: Vasodilation in the Management of Acute Congestive Heart Failure, J Card Fail, 6, 182
Colucci, 2000, Nesiritide Study Group: intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group, N Engl J Med, 343, 246, 10.1056/NEJM200007273430403
Silver, 1998, Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of acutely decompensated heart failure, J Card Fail, 4, 150A
Peacock WF, Emerman CE, Young J, on behalf of the PROACTION study group. Safety and efficacy of nesiritide for the treatment of decompensated heart failure in emergency department observation unit patients. JACC 2003;4(6)(Suppl A):336A.
Colucci, 1996, US Carvedilol Study Group: carvedilol inhibits clinical progression in patients with mild symptoms of heart failure, Circulation, 94, 2800, 10.1161/01.CIR.94.11.2800
Tsuyuki, 1998, Eur Heart J, 19S, 308
The International Steering Committee, 1997, Rationale, design, and organization of the Metoprolol CR/XL randomized intervention trial in heart failure (MERIT-HF), Am J Cardiol, 80, 54J, 10.1016/S0002-9149(97)00841-2
CIBIS Investigators and Committees, 1994, A randomized trial of beta-blockade in heart failure: The Cardiac Insufficiency Bisoprolol Study (CIBIS), Circulation, 90, 1765, 10.1161/01.CIR.90.4.1765
Bristow, 1996, MOCHA Investigators: carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure, Circulation, 94, 2807, 10.1161/01.CIR.94.11.2807
The Rales Investigators, 1996, Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (The Randomized Aldactone Evaluation Study [RALES]), Am J Cardiol, 78, 902, 10.1016/S0002-9149(96)00465-1
Cioffi, 1996, Systemic thromboembolism in chronic heart failure. A prospective study in 406 patients, Eur Heart J, 17, 1381, 10.1093/oxfordjournals.eurheartj.a015073
Baker, 1994, Management of heart failure. IV. Anticoagulation for patients with heart failure due to left ventricular systolic dysfunction, JAMA, 272, 1614, 10.1001/jama.1994.03520200070038
Turpie, 2000, Thrombosis prophylaxis in the acutely ill medical patient: insights from the prophylaxis in MEDical patients with ENOXaparin (MEDENOX) trail, AJC, 86, 48M, 10.1016/S0002-9149(00)01481-8
ACC/AHA, 1995, Guidelines for the evaluation and management of heart failure: report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee of Evaluation and Management of Heart Failure), Circulation, 92, 2764, 10.1161/01.CIR.92.9.2764
Elkayam, 1985, Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure, Am J Cardiol, 56, 560, 10.1016/0002-9149(85)91185-3
Barjon, 1987, Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure, J Am Coll Cardiol, 9, 622, 10.1016/S0735-1097(87)80057-8
Elkayam, 1990, A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure, Circulation, 82, 1954, 10.1161/01.CIR.82.6.1954
Goldstein, 1991, Diltiazem increases late-onset congestive heart failure in post-infarction patients with early reduction in ejection fraction. The Adverse Experience Committee and the Multicenter Diltiazem Post-infarction Research Group, Circulation, 83, 52, 10.1161/01.CIR.83.1.52
Batsford, 1995, Ventricular arrhythmias in heart failure, Cardiol Clin, 13, 87, 10.1016/S0733-8651(18)30064-X
The Cardiac Arrhythmia Suppression Trail (CAST) Investigators, 1989, Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction, N Engl J Med, 321, 406, 10.1056/NEJM198908103210629
Albert, 1999, Manipulating survival and life quality outcomes in heart failure through disease state management, Crit Care Nurse Clin North Am, 11, 121, 10.1016/S0899-5885(18)30157-6
Cline, 1998, Cost effective management program for heart failure reduces hospitalization, Heart, 80, 442, 10.1136/hrt.80.5.442
Fonarow, 1997, Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure, J Am Coll Cardiol, 30, 725, 10.1016/S0735-1097(97)00208-8